The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term outcomes of liver transplantation (LT) for the treatment of neuroendocrine liver metastases (NELM): The Mayo Clinic experience.
 
Mohamad Bassam Sonbol
No Relationships to Disclose
 
Matthew Buras
No Relationships to Disclose
 
Daniel H. Ahn
Consulting or Advisory Role - Celltrion (I); Merrimack
 
Mitesh J. Borad
Stock and Other Ownership Interests - Gilead Sciences; GlaxoSmithKline
Consulting or Advisory Role - Agios (Inst); ArQule (Inst); Celgene (Inst); Fujifilm (Inst); G1 Therapeutics; Halozyme (Inst); Inspyr Therapeutics; Insys Therapeutics (Inst); Novartis (Inst); TD2
Research Funding - Agios (Inst); ARIAD (Inst); BiolineRx (Inst); Boston Biomedical (Inst); Celgene (Inst); Dicerna (Inst); Eisai (Inst); EMD Serono (Inst); Halozyme (Inst); ImClone Systems (Inst); Incyte (Inst); Isis Pharmaceuticals (Inst); MedImmune (Inst); miRNA Therapeutics (Inst); Senhwa Biosciences (Inst); Sillajen (Inst); Sun Biopharma (Inst); Sun BioPharma (Inst); Taiho Pharmaceutical (Inst); Threshold Pharmaceuticals (Inst); Toray Industries (Inst)
Travel, Accommodations, Expenses - ArQule; AstraZeneca; Celgene
 
Gregory J. Gores
No Relationships to Disclose
 
Amit Mathur
No Relationships to Disclose
 
Julie Heimbach
No Relationships to Disclose
 
Thomas DeLeon
No Relationships to Disclose
 
C.Burcin Taner
No Relationships to Disclose
 
Thorvardur Ragnar Halfdanarson
Consulting or Advisory Role - Ipsen (Inst); Lexicon (Inst); Merrimack (Inst)
Research Funding - Boston Biomedical (Inst); Esanex (Inst); Ipsen (Inst)
 
Timothy J. Hobday
No Relationships to Disclose
 
Ramesh K. Ramanathan
Honoraria - Cerulean Pharma; Insys Therapeutics; Novocure; Pharmacyclics; Taiho Pharmaceutical
Consulting or Advisory Role - Cerulean Pharma; Insys Therapeutics; Novocure; Pharmacyclics
Research Funding - Abbvie (Inst); Berg Pharma (Inst); Boston Biomedical (Inst); Celgene (Inst); Merck/Schering Plough (Inst); Merrimack (Inst); Superlab Far East (Inst)
 
Kabir Mody
Consulting or Advisory Role - Celgene; Genentech/Roche; Merrimack
Research Funding - ARIAD; FibroGen; MedImmune; Senhwa Biosciences; TRACON Pharma
 
Chee-Chee H. Stucky
No Relationships to Disclose
 
Mark J. Truty
No Relationships to Disclose
 
Adyr A Moss
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Genentech/Roche; Glenmark; Lilly; Merrimack; NCCN; Pfizer; Research to Practice; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Merck; Polaris